---
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/267411222.md"
description: "The Nasdaq Biotechnology Index closed up nearly 1.4%, closely mirroring the performance of the Dow Jones Industrial Average. Among the constituent stocks, Esperion rose 16.09%, ARS Pharmaceuticals rose 15.50%, Anavex Life Sciences rose 12.34%, Personalis rose 12.31%, Autolus Therapeutics rose 12.10%, and Aura Biosciences rose 11.09%. AC Immune fell 5.84%, LENZ Therapeutics fell 6.51%, and Cullinan Oncology LLC fell 8.82%"
datetime: "2025-11-25T21:27:57.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/267411222.md)
  - [en](https://longbridge.com/en/news/267411222.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/267411222.md)
generator: "portal-rs"
---

# 

The Nasdaq Biotechnology Index closed up nearly 1.4%, performing close to the Dow Jones Industrial Average. Component stock Esperion rose 16.09%, ARS Pharmaceuticals rose 15.50%, Anavex Life Sciences rose 12.34%, Personalis rose 12.31%, Autolus Therapeutics rose 12.10%, and Aura Biosciences rose 11.09%. AC Immune, on the other hand, fell 5.84%, ranking third from the bottom, LENZ Therapeutics fell 6.51%, and Cullinan Oncology LLC fell 8.82%

### Related Stocks

- [PSNL.US](https://longbridge.com/en/quote/PSNL.US.md)
- [SPRY.US](https://longbridge.com/en/quote/SPRY.US.md)
- [AURA.US](https://longbridge.com/en/quote/AURA.US.md)
- [AUTL.US](https://longbridge.com/en/quote/AUTL.US.md)
- [AVXL.US](https://longbridge.com/en/quote/AVXL.US.md)

## Related News & Research

- [ISS backs Anavex board slate, urges vote for all six director nominees in proxy fight with PVG](https://longbridge.com/en/news/298918567.md)
- [UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Buys 85,969 Shares of Personalis, Inc. $PSNL](https://longbridge.com/en/news/298826485.md)
- [AVXL: Prioritizing core CNS programs and restoring compliance, with a focus on transparency and execution](https://longbridge.com/en/news/298504097.md)
- [Anavex says FDA grants meeting request on adding pediatric patients to Phase 3 Rett syndrome trial of blarcamesine](https://longbridge.com/en/news/298506026.md)
- [Autolus says FDA grants RMAT designation for obe-cel in lupus, lupus nephritis](https://longbridge.com/en/news/298445726.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**